Nasonex
Mometasone furoate is marketed under the brand name Nasonex 1. This is the most commonly recognized alternative name for this intranasal corticosteroid preparation.
Additional Brand Names and Formulations
Mometasone furoate is available under several other brand names depending on the formulation and geographic region:
- Elocon - topical cream/ointment formulation (0.1%) 2, 3
- Dezrinit - intranasal spray (registered in Russian Federation as equivalent to Nasonex) 4
- Generic formulations - approved in multiple countries including Japan (first generic approved February 2018) 5
Key Characteristics
The medication is chemically known as 9α,21-Dichloro-11β,17-dihydroxy-16α-methylpregna-1,4-diene-3,20-dione 17-(2-furoate) with molecular formula C27H30Cl2O6 2.
Available Formulations:
- Intranasal spray: 50 µg per spray (aqueous suspension) - marketed as Nasonex 1
- Topical cream/ointment: 0.1% concentration - marketed as Elocon 2, 3
- Combination products: Olopatadine/mometasone furoate (GSP301) for allergic rhinitis 6
The intranasal formulation (Nasonex) is FDA-approved for seasonal and perennial allergic rhinitis in patients ≥2 years, and for nasal polyps in adults ≥18 years 1.